je.st
news
Immunocore And Lilly Announce Immunotherapy-Based Clinical Trial Collaboration In Melanoma
2015-07-01 08:13:50| drugdiscoveryonline Home Page
Immunocore Limited and Eli Lilly and Company recently announced that they have entered into an immunotherapy-based clinical trial collaboration to explore the utility of Immunocore’s lead T-cell receptor based investigational therapeutic, IMCgp100, in combination with Lilly’s galunisertib (LY2157299) and merestinib (LY2801653) for the treatment of melanoma
Tags: trial
clinical
collaboration
announce
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||